BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis. Nyberg T, Tischkowitz M, Antoniou AC. Br J Cancer 2021 Dec 28. pii: 10.1038/s41416-021-01675.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nyberg T, Tischkowitz M, Antoniou AC. BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis. Br J Cancer 2021 Dec 28. pii: 10.1038/s41416-021-01675.
PMID: 34963702